I have 22 consecutive profitable trades of 15% or better. How is this possible? Every day there are hundreds of stocks setting new highs, no matter what happens in the overall market. Many of these stocks are still at very reasonable valuations. Afraid of buying stocks at their highs? Think of it this way: a new high is really a future floor for companies with solid financial underpinnings. Quantitative momentum modeling makes it easy to identify stocks that can continue this upward momentum trend. Why does this happen? It's really very simple..ask me about what investors and cows have in common. I am $$$ MR. MARKET $$$. I AM HUGE!!! Bring me your finest meats and cheeses. You can join in on the fun. Register for free and you'll be able to post messages on this forum and also receive emails when $$$ MR. MARKET $$$ makes his own trades. ($$$MR. MARKET$$$ is a proprietary investor and does not provide individual financial advice. The stocks mentioned on this forum do not represent individual buy or sell recommendations and should not be viewed as such. Individual investors should consider speaking with a professional investment adviser before making any investment decisions.)
If this is your first visit, be sure to
check out the FAQ by clicking the
link above. You may have to register
before you can post: click the register link above to proceed. To start viewing messages,
select the forum that you want to visit from the selection below.
WHAT???? Louetta is back???...I was just asking if anyone had heard from you on my chat a month or so ago.
Still in Academia???
I am indeed back. Even bought one of our fearless leaders picks a week or so ago. 'Fraid I'm not in academia any more, failed the PhD qualifiers. They fiinally figured out I only got into college because I could swim. Thank you for asking. How are you?
Would you care to opine on AMRN? 'Preciate any input you may have...
Hi Louetta! Welcome back! I am holding some AMRN on all the takeover rumors. But you know what those rumors are worth. http://seekingalpha.com/article/2520...ce=marketwatch
It has an apparently fantastic drug to lower triglycerides when taken with a statin. Since Lipitor is coming off patent soon, it is thought that maybe GSK or PFE are interested. The CEO keeps bragging that the company has more suitors than the 17 staff they have. Get a load of the institutional ownership! http://whalewisdom.com/stock/amrn
ALSO from 2/11/11: Posted: Mon Feb 14, 2011 2:01 pm
ronpopeil Share Monday, February 14, 2011 12:29:17 PM
Re: Biorunner post# 40142 Post # of 40153
AMRN - From Maffais.com (off the yahoo board)
WOW! Instituitional Activity is picking up Nicely!
These were filed on 2-11-11
Levin Capital Strategies L P added 76,000
Knott David M Sold all -516,213
Suttonbrook Capital Management Lp new holding 449,700
Susquehanna International Group Llp new holding45,605
Renaissance Technologies Corp added 486,444
Knight Capital Group Inc added 22,279
Franklin Resources Inc added 83,000
Duquesne Capital Management L L C new holding 700,000
Bank Of New York Mellon Corp added more 3,223,400
Previous Shares Held By Institutions 31,636,393 Net Shares Changed (Pct): 6,446,975 (20.37%)
Current Shares Held By Institutions "Don't worry about the world coming to an end today. It's already tomorrow in Australia"
The MARINE phase 3 trials have met the primary endpoint and an NDA is expected soon in 2011. http://investor.amarincorp.com/relea...leaseID=533361
The ANCHOR phase 3 trials are underway. If successful NDA and good ANCHOR results, the drugs could be block busters and pose a threat to any generic Lipitor. http://clinicaltrials.gov/ct2/show/N...=amarin&rank=2
I don't know, anybody's guess at this point. It could be a long wait. But the price is right and I'm willing to wait a while but bail at bad news.
Thank you R.B. for that detailed response. I was kind of hoping AMRN might manage to stay independent and might make a decent long-term holding if their drugs are successful. Not sure how practical that hope is.
SLTM is one I think is interesting. They seem to have a couple of new products and the stock has moved recently.
Gotta hand it to you. This is one I hadn't heard about before. It's not exactly a "baby biotech" but a medical device/aesthetics company. No guys, it has nothing to do with anaesthetics, but everything to do with looking younger.
I think the runup might be preceding 2010 earnings on 2/22. Volume way above average daily. Interesting. I'm not a good balance sheet reader but aren't they actually losing money on paper? Thanks for mentioning it!
I am indeed back. Even bought one of our fearless leaders picks a week or so ago. 'Fraid I'm not in academia any more, failed the PhD qualifiers. They fiinally figured out I only got into college because I could swim. Thank you for asking. How are you?
I'm Super Duper...After being laid off for a year and just day trading which went well I went back to work w/ my old company on 12/1...Moved from LA to Sacramento which actually is pretty nice altho Forbes rated it # 5 on the Misery Index. Unemployment very high here (Worst employment gain of 36 metro areas last year...Actually it was -2.2% as I recall)...Basketball team stinks...But people are generally nicer than in LA and it is really cheap.
Thanks, Doug
"Trade What Is Happening...Not What You Think Is Gonna Happen"
Gotta hand it to you. This is one I hadn't heard about before. It's not exactly a "baby biotech" but a medical device/aesthetics company. No guys, it has nothing to do with anaesthetics, but everything to do with looking younger.
I think the runup might be preceding 2010 earnings on 2/22. Volume way above average daily. Interesting. I'm not a good balance sheet reader but aren't they actually losing money on paper? Thanks for mentioning it!
Thank you for your input. In truth they are losing money which makes it more interesting to try to decipher what's going on. Another interesting case methinks is JAZZ. The FDA declined to approve in early October their JZP-6 drug for fibromylagia and the stock has done nothing but go up since then. (About $10 to about $23.) I sold at $15 because I could see no reason for further increase. Whoops.
Thank you for your input. In truth they are losing money which makes it more interesting to try to decipher what's going on. Another interesting case methinks is JAZZ. The FDA declined to approve in early October their JZP-6 drug for fibromylagia and the stock has done nothing but go up since then. (About $10 to about $23.) I sold at $15 because I could see no reason for further increase. Whoops.
Seems to be an IBD favorite and was a wall street darling until the FDA shot them down. Your question is a good one, echoed by a zoo board enthusiast on 2/16: "Left this stock after FDA shot them down, what made them double since? Looking for both bull and bear cases. Pls more than pos/go jazz if youd be so kind. Thanks in advance." No replies yet.
Have done a little looking at my favorite sites, but no answers I could see. Maybe a takeover candidate, according to Barron's in January. Other than that, no big explanation. P.S., you do know where the word "jazz" came from, as in the music "jass", as in "jass me baby." Don't get jassed, Lou. LOL
Association with sex: The association of jazz with sex is early and extensive. The Historical Dictionary of American Slang (1997) cites explicit sexual meanings from 1918 and says that this was probably the original sense. However, it now seems difficult to reconcile a prior, widely recognized sexual meaning of jazz with the known word history described above. Professor Gerald Cohen of Missouri University of Science and Technology, who has done a great deal of work on the word's history, in 2001 offered a $100 reward for any provable musical or sexual use of jazz from before 1913, an offer that still stands[citation needed].
Vet Boswell of the Boswell Sisters said she remembered when "jazz" was not a word fit to be uttered in polite company[citation needed]. Ray Lopez of Tom Brown's 1915 band recalled he and his fellow musicians assumed that the word "jass" or "jazz" was too improper to be printed in newspapers so they looked in a dictionary for similar words like "jade"; rediscovered newspaper advertisements from the era for Brown's "Jad Band" or "Jab Band" are suggestive of confirmation of this account[citation needed].
Jazz is said to be a variation of the word "jism," because it was originally performed by horn players to entertain johns in the whorehouses of Storyville, the notorious red-light district of New Orleans. It was what was playing downstairs when one lost that last shred of innocence. Trombonist Clay Smith was rumored to have said, "If the truth were known about the origin of the word 'jazz,' it would never be mentioned in polite company."[citation needed] http://en.wikipedia.org/wiki/Jazz_(word)
There's your spice for the day guys and gals. Just livened up this forum. Hee
Seems to be an IBD favorite and was a wall street darling until the FDA shot them down. Your question is a good one, echoed by a zoo board enthusiast on 2/16: "Left this stock after FDA shot them down, what made them double since? Looking for both bull and bear cases. Pls more than pos/go jazz if youd be so kind. Thanks in advance." No replies yet.
Have done a little looking at my favorite sites, but no answers I could see. Maybe a takeover candidate, according to Barron's in January. Other than that, no big explanation. P.S., you do know where the word "jazz" came from, as in the music "jass", as in "jass me baby." Don't get jassed, Lou. LOL
snip
Hee
One explanation I heard is as follows. The FDA said the new JAZZ drug is safe and efficacious for use by fibromylagia patients. It was rejected because of it's possible use as a date rape drug. Evidently, however, JAZZ has another drug which is very similar to the new one and it is thought that doctors will prescribe this other drug for fibromylagia. I gather this is quite legal, there is even a name for the practice of using a drug for another application. So, JAZZ will make money anyway.
I guess also it seems likely some sort of regimen can be devised for use of the drug which will will satisfy the date rape concerns. Narcotics and anabolic steroids can be dispensed under proper control so why not this. Who knows.
Another one I'm interested in is CORT. I see them as similar to AMRN, new drug(s) near (hopefully) approval. They have recently completed a stock offering to fund research and commercialization activities so the offering is in the stock price. May calls at $2.50 sell with little premium which looks like a good buy but is actually a bit suspicious methinks.
Another one I'm interested in is CORT. I see them as similar to AMRN, new drug(s) near (hopefully) approval. They have recently completed a stock offering to fund research and commercialization activities so the offering is in the stock price. May calls at $2.50 sell with little premium which looks like a good buy but is actually a bit suspicious methinks.
This link doesn't seem to pull any punches. I haven't heard anything about the IPO except that KKR and Bain Capital aren't bad names to be buying from. I'll let you know if Barron's has something over the weekend.
Comment